Pemphigus Vulgaris Therapy Pipeline Expands Beyond Rituximab
A new EMJ review details how pemphigus vulgaris treatment is broadening beyond rituximab, with pipeline candidates targeting faster remission and better safety.
Topic
Rituximab
Topic
Topic
Topic
A new EMJ review details how pemphigus vulgaris treatment is broadening beyond rituximab, with pipeline candidates targeting faster remission and better safety.